simplyStocks
Solventum
SOLV · NYSEHealthcare / Medical Devices
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
~$13B
Revenue (2025)
$8.3B
Rev. growth
+0.9%
EPS (GAAP)
$8.88
Adj. EPS
$6.11
Profit margin
~19%
Div yield
0%
Operating margin
~26%
In plain English
Solventum is 3M's former healthcare arm, spun off as its own company on April 1, 2024. It makes the unglamorous-but-everywhere products of modern medicine: negative-pressure wound dressings, surgical tapes, IV-site protectors, sterilization indicators and the iconic Littmann stethoscope, plus dental cements and braces and the software hospitals use to code and bill care. In 2025 it sharpened its focus by selling its Purification & Filtration arm to Thermo Fisher.
In simple terms
What Solventum really sells
Solventum is 3M's former healthcare arm, spun off as its own company on April 1, 2024. It makes the unglamorous-but-everywhere products of modern medicine: negative-pressure wound dressings, surgical tapes, IV-site protectors, sterilization indicators and the iconic Littmann stethoscope, plus dental cements and braces and the software hospitals use to code and bill care. In 2025 it sharpened its focus by selling its Purification & Filtration arm to Thermo Fisher.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
SteadierMore speculative
Why this rating?